CAMPSQ17772
Title : USCL-K1
Source : Synthetic construct
PubMed : 25069750
Activity : Antibacterial
Gram Nature : Gram -ve, Gram +ve
Target :
MIC [MIC at 4% BSA] for S. aureus ATCC 29213 = 8 [512], MRSA ATCC 33592 = 16 [512], MSSE CANWARD-2008 81388 = 4 [256], MRSE CAN-ICU 61589 = 4 [256], E. faecalis ATCC 29212 = 16 [512], E. faecium ATCC 27270 = 8 [512], S. pneumoniae ATCC 49619 = 64 [32], E. coli ATCC 25922 = 8 [512], E. coli CAN-ICU 61714 = 8 [512], E. coli CAN-ICU 63074 = 16 [512], E. coli CANWARD-2011 97615 = 8 [512], P. aeruginosa ATCC27853 = 16 [>512], P. aeruginosa CAN-ICU 62308 = 64 [512], P. aeruginosa CANWARD-2011 96846 = 32 [>512], S. maltophilia CAN-ICU 62584 = 256 [>512], A. baumannii CAN-ICU 63169 = 256 [>512], K. pneumoniae ATCC 13883 = 32 [>512]
Validated : Experimentally validated
Comment : Lipopeptides; N-terminal: C16; C-terminal: NH2
Sequence:
KKKK

| © 2022, Biomedical Informatics Centre, ICMR-NIRRCH |
ICMR-National Institute for Research in Reproductive and Child Health, Jehangir Merwanji Street, Parel, Mumbai-400012
Maharashtra, India